0001209191-23-010607.txt : 20230217 0001209191-23-010607.hdr.sgml : 20230217 20230217162244 ACCESSION NUMBER: 0001209191-23-010607 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221215 FILED AS OF DATE: 20230217 DATE AS OF CHANGE: 20230217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chacko Jacob CENTRAL INDEX KEY: 0001608936 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39269 FILM NUMBER: 23642927 MAIL ADDRESS: STREET 1: C/O IGNYTA, INC. STREET 2: 11095 FLINTKOTE AVE., SUITE D CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oric Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001796280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 471787157 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 240 E. GRAND AVE. STREET 2: 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 388-5600 MAIL ADDRESS: STREET 1: 240 E. GRAND AVE. STREET 2: 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2022-12-15 2022-12-16 0 0001796280 Oric Pharmaceuticals, Inc. ORIC 0001608936 Chacko Jacob C/O ORIC PHARMACEUTICALS, INC. 240 E. GRAND AVE., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CEO Common Stock 2022-12-15 4 S 0 6137 3.073 D 816652 D This amendment is filed to correct the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person. /s/ Christian Kuhlen, attorney-in-fact 2023-02-17